In a 2011 study by Gu et al. [50], they found ROS tyrosine kinase activity may be involved in the growth and survival of CCA cancer cells, making ROS1 inhibitors potentially useful in controlling disease. The gene discussed is ROS1; the disease is cholangiocarcinoma.